Ovoca Bio | OVG - Debt


Ovoca Bio reported EUR0 in Debt for its fiscal semester ending in June of 2021.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
ALKERMES USD 1.58B 1.51B Mar/2026
Avita Medical AUD 46.05M 1.46M Dec/2025
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Great Western Mining Corporation EUR 0 0 Dec/2021
Ionis Pharmaceuticals USD 2.34B 9.5M Mar/2026
IQVIA Holdings USD 15.83B 109M Mar/2026
Malin Corporation EUR 100K 0 Dec/2023
Moderna USD 1.31B 571M Dec/2025
Organon & Co USD 8.64B 184M Dec/2025
Ovoca Bio EUR 0 0 Jun/2021
Revvity USD 3.4B 29.2M Dec/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.34B 69.3M Mar/2026
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025